Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.

Quality of Life Clinical Trial

Official title: Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to learn whether showering with surgical drain tubes in place after first stage breast reconstruction causes increased risk of infection. The main questions it aims to answer are:

• Is there an increased risk of infection/complications with showering 48 hours after drain tubes are in place

• Does showering after 48 hours with drain tubes in place affect quality of life.

Clinical Trial Description

SSI (soft tissue infection) is an aggravating risk specifically associated with implants. Breast reconstruction quotes infection rates anywhere from 1-35% while cosmetic augmentations quote rates around 1.5%. Usually, the causative organisms are skin flora like Staph aureus and Staph epidermidis. Occasionally mycobacterium and other atypical bacterium are isolated more commonly in the immunocompromised. Despite perioperative antibiotics, SSI is still a prevalent complication increasing total expenditure of patients and hospital systems upwards of $4000/patient in reoperation fees and hospital stay costs. Skin prep and antibiotics in the preoperative phase is very important to the sterile technique and decreasing risk of infection by decreasing bacterial load at the time of incision and surgery. However, postoperative care and interventions are less strictly evaluated and defined. Currently, there is no standard of care in regards to showering post operatively with JP (Jackson-Pratt) drains in place. Timing of showering is ultimately based on surgeon preference. In practice, the investigators routinely have had patients wait to shower until the JP drains are removed. The investigators hypothesize that showering daily, even with drains in place, will not increase rates of infection in breast reconstruction and perhaps improve quality of life during first stage. This study is prospective with participants randomized to either shower daily after 48hrs or standard of care and shower after drains removed. The participants will be asked to fill out a quality of life survey 90 days after enrollment. The patients will also be monitored for signs of infection for 90 days. ;

Related Conditions & MeSH terms

• Communicable Diseases
• Infections
• Quality of Life

• NCT number: NCT05846438
• Study type: Interventional
• Source: University of Missouri-Columbia
• Status: Recruiting
• Phase: N/A
• Start date: March 15, 2023
• Completion date: March 15, 2025